Navigation Links
Progress on HIV/AIDS significant but insufficient

United Nations Secretary-General Kofi Annan shared his hope with a gathering of senior world officials at Headquarters that the 2001 Declaration of Commitment on HIV/AIDS would have heralded a response that matched the epidemic's scale, yet progress had been "significant but insufficient".

Citing achievements in the core areas of political leadership, funding, the intensity and reach of prevention programmes, and the availability of drug therapies, he said, however, that last year saw more new infections and more AIDS-related deaths than ever before. With the epidemic expanding at an accelerating rate and on every continent, treatment and prevention efforts were "nowhere near enough". For example, only 12 per cent of the people in need of antiretroviral therapies in low- and middle-income countries were receiving them.

He called for increased resources, better planning, better and more vocal leadership, and real investment in the empowerment of women and girls. Women now accounted for about half of all people living with HIV worldwide, but they were also the most courageous and creative champions in that fight. How the international community fared in the fight was crucial; only by meeting the challenge could it succeed in its efforts to build a humane, healthy and equitable world.

General Assembly President Jean Ping (Gabon) said that the HIV/AIDS threat in 2005 was much greater than when the Assembly met here four years ago. In every way, that threat had attained alarming proportions. In fact, he said, in 2004, the number of infected people had grown to about 5 million, and the number who had died had also grown, to 3.1 million in 2004, much more than for the four preceding years. The pandemic had also grown disturbingly worldwide, affecting new countries and new populations within countries, particularly women and girls, and 95 per cent of those infected were in low- and medium-income countries.

Given the quantum worsening in the ep
'"/>

Source:United Nations


Page: 1 2 3 4

Related biology news :

1. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
2. AIDS Public Awareness Campaign Expands Following Report Of Rapidly Progressive HIV
3. Progress being made in exploring potential use of stem cells to treat heart disease
4. Progress made in HIV vaccine development
5. Progress toward artificial photosynthesis?
6. New therapy for HIV/AIDS eliminates needles and excessive toxicity
7. South Africa still debating how to tackle HIV/AIDS when 5 million are infected
8. AIDS expert says global strategy needed to combat feminization of HIV/AIDS
9. HIV/AIDS rates in Tijuana, Mexico increasing at alarming rate
10. International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy
11. Study defines effective microbicide design for HIV/AIDS prevention
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Progress HIV AIDS significant but insufficient

(Date:4/9/2015)... SAN JOSE, Calif. , April 9, 2015 /PRNewswire/ ... of human interface solutions, announced today that it will ... 2015 on Thursday, April 23, 2015, after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
(Date:4/2/2015)... , April 2, 2015 ... tests DERMALOG by far outperforms the strongest competitors, ... maintaining high accuracy, the system is capable of ... the speed proves up to be ten times ... than its runner-up performance.      (Photo: ...
(Date:4/2/2015)... , April 2, 2015 Fingerprint ... fingerprint sensor FPC1025 from the distributor World Peace Industrial ... during Q2 2015 although the major part of the ... will be used by smartphone manufacturers in ... is included in the communicated revenue guidance of + ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2
... and two collaborators have received a $3.4 million research ... of prostate cancer using MRI, or magnetic resonance imaging. ... two years from the American Recovery and Reinvestment Act ... of Health under an initiative to promote industry and ...
... A new internet-based tool for designing agricultural terraces ... optimize design by allowing rapid development of alternative layouts. ... Resource: Engineering & Technology for a Sustainable World , ... Engineering at the University of Missouri, introduces a web-based, ...
... species are not just discovered in exotic localeseven places ... plants and animals. Academy scientists recently named a new ... fishes distantly related to sharks, from the coast of ... the Eastern Pacific black ghostshark ( Hydrolagus melanophasma ), ...
Cached Biology News:Rutgers to collaborate in $3.4 million effort to improve prostate cancer identification using MRI 2Web-based innovation improves, eases agricultural terrace design 2New species of ghostshark from California and Baja California 2
(Date:4/16/2015)... San Francisco, CA (PRWEB) April 16, 2015 ... is scheduled to report first quarter results on Thursday, ... the announcement, Cytokinetics’ senior management will host a conference ... and financial results and the company’s outlook for the ... and can be accessed from the homepage and in ...
(Date:4/16/2015)... 16, 2015 According to the ... an outside source was ranked first among the ... related to lifting, pushing, pulling, holding, carrying, or ... costs. The David Round Company takes statistics like ... working hard to develop and design equipment that ...
(Date:4/16/2015)... 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... joint venture with G-treeBNT (ReGenTree LLC) has retained ... trial for the orphan disorder, neurotrophic keratopathy (NK), ... eye syndrome (DES) in the U.S.  Both trials ... this year.  Each of these eye disorders was ...
(Date:4/16/2015)... Calif. , April 16, 2015  Scientists from ... "New Drugs on the Horizon," at the American Association ... Philadelphia, PA on Sunday, April 19, 2015 ... Ph.D., Cleave,s Director of Biology, will present new in ... a first-in-class, oral inhibitor of p97, a critical enzyme ...
Breaking Biology Technology:Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 3
... to the Advanced Performance of the A1 Series of ... , MELVILLE, N.Y., Dec. 15 Offering ... Nikon Instruments, Inc.,s ( www.nikoninstruments.com ) A1 series of ... software brings biological imaging to life. The software, ...
... Scientific,Corporation (NYSE: BSX ) today announced that ... Express(R) SD Renal Monorail(R),Premounted Stent System for use as ... lesions of the renal arteries. The,Express SD System ... renal arteries in the United States. It is ...
... 15 Cylene Pharmaceuticals today announced,the initiation of ... in,patients with carcinoid/neuroendocrine tumors (C/NET), which are malignant,cancers ... "Quarfloxin (CX-3543) is a ... in the abnormal nucleoli of cancer cells, thereby,selectively ...
Cached Biology Technology:Nikon Instruments A1 Confocal Laser Microscope Series With NIS-Elements C Software Delivers Fully Integrated Comprehensive Confocal Imaging Capabilities 2Nikon Instruments A1 Confocal Laser Microscope Series With NIS-Elements C Software Delivers Fully Integrated Comprehensive Confocal Imaging Capabilities 3FDA Approves Boston Scientific's Express(R) SD Renal Stent System 2FDA Approves Boston Scientific's Express(R) SD Renal Stent System 3FDA Approves Boston Scientific's Express(R) SD Renal Stent System 4Cylene Pharmaceuticals Initiates Phase II Clinical Trial of Quarfloxin (CX-3543) in Patients With Carcinoid/Neuroendocrine Tumors 2Cylene Pharmaceuticals Initiates Phase II Clinical Trial of Quarfloxin (CX-3543) in Patients With Carcinoid/Neuroendocrine Tumors 3
... Inhibitor is a recombinant protein that has been ... in the preparation of cDNA by reverse transcription, ... protein synthesis. RNA Safe Inhibitor tightly binds RNases ... range of eukaryotic RNases such as RNase A, ...
... Inhibitor (Ribonuclease inhibitor) is a ... to inhibit RNase activity. It ... endonuclease activity. , Inhibits ... RNA template , Lacks ...
... acids ,The GC-RICH PCR System, a ... proofreading polymerase, powers through templates that are ... polymerases and other blends of polymerases. The ... unique GC-RICH Resolution Solution combine to deliver ...
... of optimized cell lines in combination with ... parameters. Nucleofector Kits are only functional in ... lines can be transfected with this kit. ... in brackets in percent (Efficiency [%] / ...
Biology Products: